510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K181368Substantially Equivalent

VITEK 2 AST-YS Micafungin (<=0.06 - =>8 µg/mL)

bioMerieux, Inc., Hazelwood MO / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K181368 is the FDA 510(k) clearance record for VITEK 2 AST-YS Micafungin (<=0.06 - =>8 µg/mL), a class II device, cleared for bioMerieux, Inc. on under FDA product code NGZ (Susceptibility Test Plate, Antifungal). FDA's definition for product code NGZ reads: "The device is an in vitro diagnostic device intended for use in determining quantitative susceptibility of Candida species to various antifungal agents diluted in varying concentration in a microtiter plate format". FDA records list 408 510(k) clearances for bioMerieux, Inc., from to . As of , FDA records show no recalls naming K181368.

Clearance record

Decision date
Received
(28 days to decision)
Product code
NGZ Susceptibility Test Plate, Antifungal
Regulation
21 CFR 866.1640
Device class
Class II
Review panel
Microbiology
Applicant
bioMerieux, Inc. 595 Anglum Rd., Hazelwood MO
510(k) summary
Summary PDF
Third party review
No

Clearances, product code NGZ

Trailing 12 months

FDA records hold no clearances under product code NGZ in the trailing twelve months.

FDA records show no clearances under product code NGZ in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code NGZ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260